Oxford Biomedica plc (LON:OXB)

Oxford Biomedica Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	780	744	445	213	426	1,059
Market Cap Growth	142.40%	67.15%	108.92%	-50.00%	-59.79%	24.98%
Enterprise Value	831	795	479	223	453	1,008
Last Close Price	6.45	6.17	4.20	2.20	4.42	12.30
PE Ratio	-	-	-	-	-	55.72
Forward PE	-	-	-	-	-	60.29
PS Ratio	4.62	4.41	3.46	2.38	3.04	7.42
PB Ratio	8.54	8.14	7.36	2.74	1.80	5.66
P/TBV Ratio	11.78	11.24	15.99	4.95	4.31	5.66
P/FCF Ratio	-	-	-	-	-	66.23
P/OCF Ratio	1538.09	1466.91	-	-	-	41.62
EV/Sales Ratio	4.92	4.71	3.72	2.49	3.24	7.06
EV/EBITDA Ratio	-	-	-	-	-	30.85
EV/EBIT Ratio	-	-	-	-	-	45.53
EV/FCF Ratio	-195.35	-	-	-	-	63.01
Debt / Equity Ratio	1.62	1.62	1.80	1.43	0.48	0.05
Debt / EBITDA Ratio	-	-	-	-	-	0.27
Debt / FCF Ratio	-	-	-	-	-	0.58
Net Debt / Equity Ratio	0.56	0.56	0.80	0.10	-0.11	-0.53
Net Debt / EBITDA Ratio	-2.80	-2.80	-2.01	-0.11	0.87	-3.05
Net Debt / FCF Ratio	-12.04	-12.04	-0.83	-0.20	0.93	-6.23
Asset Turnover	0.61	0.61	0.53	0.25	0.40	0.68
Inventory Turnover	6.65	6.65	5.73	3.91	6.40	7.32
Quick Ratio	1.92	1.92	1.98	2.80	3.33	4.54
Current Ratio	2.20	2.20	2.28	3.19	3.61	4.92
Return on Equity (ROE)	-40.37%	-40.37%	-70.28%	-117.29%	-21.32%	12.67%
Return on Assets (ROA)	-6.98%	-6.98%	-10.54%	-15.07%	-8.33%	6.57%
Return on Invested Capital (ROIC)	-21.81%	-24.77%	-42.05%	-58.29%	-31.30%	25.31%
Return on Capital Employed (ROCE)	-12.90%	-12.90%	-23.60%	-41.30%	-11.60%	10.90%
Earnings Yield	-3.86%	-4.05%	-9.71%	-73.95%	-9.19%	1.80%
FCF Yield	-0.55%	-0.57%	-13.07%	-18.01%	-6.79%	1.51%
Buyback Yield / Dilution	-8.18%	-8.18%	-7.15%	-1.82%	-10.76%	-7.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.